JPWO2023074847A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023074847A5
JPWO2023074847A5 JP2023556670A JP2023556670A JPWO2023074847A5 JP WO2023074847 A5 JPWO2023074847 A5 JP WO2023074847A5 JP 2023556670 A JP2023556670 A JP 2023556670A JP 2023556670 A JP2023556670 A JP 2023556670A JP WO2023074847 A5 JPWO2023074847 A5 JP WO2023074847A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
ring
aliphatic heterocyclic
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023556670A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023074847A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/040370 external-priority patent/WO2023074847A1/ja
Publication of JPWO2023074847A1 publication Critical patent/JPWO2023074847A1/ja
Publication of JPWO2023074847A5 publication Critical patent/JPWO2023074847A5/ja
Pending legal-status Critical Current

Links

JP2023556670A 2021-10-29 2022-10-28 Pending JPWO2023074847A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021177933 2021-10-29
PCT/JP2022/040370 WO2023074847A1 (ja) 2021-10-29 2022-10-28 新規スピロ化合物

Publications (2)

Publication Number Publication Date
JPWO2023074847A1 JPWO2023074847A1 (cg-RX-API-DMAC7.html) 2023-05-04
JPWO2023074847A5 true JPWO2023074847A5 (cg-RX-API-DMAC7.html) 2024-07-18

Family

ID=86159495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556670A Pending JPWO2023074847A1 (cg-RX-API-DMAC7.html) 2021-10-29 2022-10-28

Country Status (12)

Country Link
US (1) US20260132127A1 (cg-RX-API-DMAC7.html)
EP (1) EP4438594A1 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023074847A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240091009A (cg-RX-API-DMAC7.html)
CN (1) CN118176179A (cg-RX-API-DMAC7.html)
AR (1) AR127489A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022379243A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236538A1 (cg-RX-API-DMAC7.html)
IL (1) IL312247A (cg-RX-API-DMAC7.html)
MX (1) MX2024005187A (cg-RX-API-DMAC7.html)
TW (1) TW202325272A (cg-RX-API-DMAC7.html)
WO (1) WO2023074847A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024020156A1 (en) * 2022-07-22 2024-01-25 Biogen Ma Inc. Emopamil-binding protein inhibitors and uses thereof
CN117603226B (zh) * 2023-11-27 2025-08-01 成都大学 一种吡唑并氮氧双杂卓类化合物及其制备方法和用途
AU2024424270A1 (en) * 2024-02-01 2026-08-13 Foresight Therapeutics (Hefei) Co., Ltd. Spiro derivative serving as wrn inhibitor and use of spiro derivative

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20000240A1 (en) 2000-02-17 2003-03-05 Trinity College Dublin TRH-like peptide derivatives
TWI285110B (en) 2000-08-31 2007-08-11 Shionogi & Co Parkinson disease therapeutic agent
EP1794182B1 (en) 2004-10-01 2015-06-03 The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin Compounds that modulate trh actions and inhibit the trh-degrading enzyme
IE20060253A1 (en) 2006-03-31 2007-11-14 Trinity College Dublin Methods for modulating the levels and effects of thyrotropin-releasing hormone(trh)and trh-related peptides
WO2021204159A1 (en) * 2020-04-08 2021-10-14 Agios Pharmaceuticals, Inc. Menin inhibitors and methods of use for treating cancer
JP2023543670A (ja) * 2020-08-26 2023-10-18 ナロ・セラピューティクス Mycファミリー癌原遺伝子タンパク質のモジュレーター
AU2021409561A1 (en) * 2020-12-22 2023-07-06 Nikang Therapeutics, Inc. Compounds for degrading cyclin-dependent kinase 2 via ubiquitin proteosome pathway
WO2022224166A1 (en) * 2021-04-20 2022-10-27 Integral Biosciences Private Limited Compounds as lxr agonists

Similar Documents

Publication Publication Date Title
US12084447B2 (en) SHP2 phosphatase inhibitors and methods of use thereof
US20240417412A1 (en) Heterocyclic compounds and methods of use
JP2025525356A (ja) アザキナゾリン汎Kras阻害剤
JP5764145B2 (ja) 8−メチル−1−フェニル−イミダゾル[1,5−a]ピラジン化合物
CN111788193B (zh) Pd-1/pd-l1类小分子抑制剂及其在药物中的应用
US20240285617A1 (en) Novel heterocyclic derivatives useful as shp2 inhibitors
ES2606016T3 (es) Derivados de piperidina condensados en espiro para su uso como inhibidores del canal de potasio medular externo renal
CN112867539B (zh) 心脏肌小节抑制剂
CA3067944C (en) Bicyclic ketone compounds and methods of use thereof
US12263171B2 (en) 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
US10000484B2 (en) Inhibitors of the renal outer medullary potassim channel
WO2012085857A1 (en) 3,8-diaza-bicyclo[4.2.0]oct-3-yl amides
AU2019286312B2 (en) New isoxazolyl ether derivatives as GABA A alpha5 PAM
JP2018510203A5 (cg-RX-API-DMAC7.html)
AU2024253757A1 (en) 1h-pyrrolo[2,3-b]pyridin-4-yl]-2-oxopyrrolidine-3-carbonitrile derivatives as tyrosine kinase 2 (tyk2) inhibitors for the treatment of inflammatory diseases
CN117279896A (zh) 氨基取代的吡啶并环类化合物及其制法和用途
US20260124205A1 (en) Modulators of beta catenin and uses thereof
RU2800160C2 (ru) Новые производные простого эфира изоксазолила в качестве пам гамк a альфа5
HK40101612A (en) Shp2 phosphatase inhibitors and methods of use thereof
RU2024114426A (ru) Новое спирановое соединение
HK40044087B (en) Shp2 phosphatase inhibitors and methods of use thereof